首页> 外文期刊>Hematology, Transfusion and Cell Therapy >Successful treatment of catastrophic antiphospholipid syndrome with therapeutic plasma exchange: a case report
【24h】

Successful treatment of catastrophic antiphospholipid syndrome with therapeutic plasma exchange: a case report

机译:治疗等离子交换的灾难性抗磷脂综合征的成功治疗:案例报告

获取原文
       

摘要

The catastrophic antiphospholipid syndrome (CAPS) is an autoimmune disease associated with rapid failure of multi- ple organs and represents less than 1% of all cases of the antiphospholipid syndrome (APS). Antiphospholipid antibod- ies are present in approximately 9% of patients with pregnancy losses, 14% with stroke, 11% with myocardial infarction and 10% with deep vein thrombosis. 1 The CAPS is considered a rare but devastating variant (30–50% mortality). 2,3 It is diagnosed according to the Asherson criteria that include: an involvement of three or more organs, a rapid progression (simultaneously or in less than one week), a laboratory demonstration of antiphospholipid antibodies and histologic evidence of small vessel occlusion (may involve one or more sites and may be accompanied by vasculitis).
机译:灾难性的抗磷脂综合征(帽)是一种自身免疫性疾病,其与多Ple器官快速失效相关,占所有抗磷脂综合征(APS)的所有病例的1%。 抗磷脂抗体在约9%的妊娠损失患者中存在,14%,中风,11%,心肌梗塞10%,深静脉血栓形成。 1帽被认为是罕见但毁灭性的变体(30-50%的死亡率)。 2,3根据Asherson标准诊断,包括:三种或更多种器官的累及,快速进展(同时或不到一周),抗磷脂抗体的实验室示范和小血管闭塞的组织学证据(5月 涉及一个或多个网站,并且可能伴有血管炎)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号